DE69232687D1 - Rezeptor flk-2 von pluripotenten hämatopoetischen Stammzellen - Google Patents

Rezeptor flk-2 von pluripotenten hämatopoetischen Stammzellen

Info

Publication number
DE69232687D1
DE69232687D1 DE69232687T DE69232687T DE69232687D1 DE 69232687 D1 DE69232687 D1 DE 69232687D1 DE 69232687 T DE69232687 T DE 69232687T DE 69232687 T DE69232687 T DE 69232687T DE 69232687 D1 DE69232687 D1 DE 69232687D1
Authority
DE
Germany
Prior art keywords
flk
receptor
stem cells
hematopoietic stem
pluripotent hematopoietic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69232687T
Other languages
English (en)
Other versions
DE69232687T2 (de
Inventor
Ihor R Lemischka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Princeton University
Original Assignee
Princeton University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Princeton University filed Critical Princeton University
Publication of DE69232687D1 publication Critical patent/DE69232687D1/de
Application granted granted Critical
Publication of DE69232687T2 publication Critical patent/DE69232687T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/12—Acyclic radicals, not substituted by cyclic structures attached to a nitrogen atom of the saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70596—Molecules with a "CD"-designation not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0647—Haematopoietic stem cells; Uncommitted or multipotent progenitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
DE69232687T 1991-04-02 1992-04-02 Rezeptor flk-2 von pluripotenten hämatopoetischen Stammzellen Expired - Lifetime DE69232687T2 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US67966691A 1991-04-02 1991-04-02
US72891391A 1991-06-28 1991-06-28
US79306591A 1991-11-15 1991-11-15
US07/813,593 US5185438A (en) 1991-04-02 1991-12-24 Nucleic acids encoding hencatoporetic stem cell receptor flk-2

Publications (2)

Publication Number Publication Date
DE69232687D1 true DE69232687D1 (de) 2002-08-22
DE69232687T2 DE69232687T2 (de) 2002-11-21

Family

ID=27505386

Family Applications (5)

Application Number Title Priority Date Filing Date
DE69232687T Expired - Lifetime DE69232687T2 (de) 1991-04-02 1992-04-02 Rezeptor flk-2 von pluripotenten hämatopoetischen Stammzellen
DE69233676T Expired - Lifetime DE69233676T2 (de) 1991-04-02 1992-04-02 Rezeptor Protein Tyrosin-Kinase (FLK-1)
DE69232952T Expired - Lifetime DE69232952T2 (de) 1991-04-02 1992-04-02 Antikörper der Rezeptoren von pluripotenten hämatopoetischen Stammzellen flk-1
DE69233788T Expired - Lifetime DE69233788D1 (de) 1991-04-02 1992-04-02 Verfahren zur Isolierung von Zellen die FLK-1-Rezeptoren auf ihrer Oberfläche exprimieren
DE69233746T Expired - Lifetime DE69233746D1 (de) 1991-04-02 1992-04-02 Verfahren zur Isolierung von Zellen die FLK-2-Rezeptoren auf ihrer Oberfläche exprimieren

Family Applications After (4)

Application Number Title Priority Date Filing Date
DE69233676T Expired - Lifetime DE69233676T2 (de) 1991-04-02 1992-04-02 Rezeptor Protein Tyrosin-Kinase (FLK-1)
DE69232952T Expired - Lifetime DE69232952T2 (de) 1991-04-02 1992-04-02 Antikörper der Rezeptoren von pluripotenten hämatopoetischen Stammzellen flk-1
DE69233788T Expired - Lifetime DE69233788D1 (de) 1991-04-02 1992-04-02 Verfahren zur Isolierung von Zellen die FLK-1-Rezeptoren auf ihrer Oberfläche exprimieren
DE69233746T Expired - Lifetime DE69233746D1 (de) 1991-04-02 1992-04-02 Verfahren zur Isolierung von Zellen die FLK-2-Rezeptoren auf ihrer Oberfläche exprimieren

Country Status (7)

Country Link
US (3) US5185438A (de)
EP (6) EP1808445A3 (de)
KR (3) KR100407010B1 (de)
AU (1) AU1924892A (de)
CA (1) CA2107463C (de)
DE (5) DE69232687T2 (de)
WO (2) WO1992017486A1 (de)

Families Citing this family (94)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6582959B2 (en) * 1991-03-29 2003-06-24 Genentech, Inc. Antibodies to vascular endothelial cell growth factor
US20030206899A1 (en) * 1991-03-29 2003-11-06 Genentech, Inc. Vascular endothelial cell growth factor antagonists
US5185438A (en) * 1991-04-02 1993-02-09 The Trustees Of Princeton University Nucleic acids encoding hencatoporetic stem cell receptor flk-2
US5367057A (en) * 1991-04-02 1994-11-22 The Trustees Of Princeton University Tyrosine kinase receptor flk-2 and fragments thereof
US5270458A (en) * 1991-04-02 1993-12-14 The Trustees Of Princeton University Nucleic acids encoding fragments of hematopoietic stem cell receptor flk-2
US6331302B1 (en) * 1992-01-22 2001-12-18 Genentech, Inc. Protein tyrosine kinase agonist antibodies
US5861301A (en) * 1992-02-20 1999-01-19 American Cayanamid Company Recombinant kinase insert domain containing receptor and gene encoding same
US6228609B1 (en) * 1992-07-09 2001-05-08 Systemix, Inc. Soluble Flk-2 sequence
US5776755A (en) * 1992-10-09 1998-07-07 Helsinki University Licensing, Ltd. FLT4, a receptor tyrosine kinase
US6107046A (en) * 1992-10-09 2000-08-22 Orion Corporation Antibodies to Flt4, a receptor tyrosine kinase and uses thereof
US6824777B1 (en) 1992-10-09 2004-11-30 Licentia Ltd. Flt4 (VEGFR-3) as a target for tumor imaging and anti-tumor therapy
US5792771A (en) * 1992-11-13 1998-08-11 Sugen, Inc. Quinazoline compounds and compositions thereof for the treatment of disease
US5712395A (en) * 1992-11-13 1998-01-27 Yissum Research Development Corp. Compounds for the treatment of disorders related to vasculogenesis and/or angiogenesis
US5763441A (en) * 1992-11-13 1998-06-09 Sugen, Inc. Compounds for the treatment of disorders related to vasculogenesis and/or angiogenesis
US5981569A (en) * 1992-11-13 1999-11-09 Yissum Research Development Company Of The Hebrew University Of Jerusalem Substituted phenylacrylonitrile compounds and compositions thereof for the treatment of disease
US6177401B1 (en) 1992-11-13 2001-01-23 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften Use of organic compounds for the inhibition of Flk-1 mediated vasculogenesis and angiogenesis
CN1701814A (zh) * 1992-11-13 2005-11-30 马克斯普朗克科学促进协会 作为血管内皮生长因子受体的f1k－1
US6872699B2 (en) 1992-11-13 2005-03-29 Max-Planck-Gesellschaft Zur Foerderung Der Wissenschaften, E.V. Truncated Flk-1 receptor protein, methods of use and a recombinant vector containing a nucleotide encoding the truncated Flk-1 protein
WO1994019463A2 (en) * 1993-02-16 1994-09-01 Auckland Uniservices Limited Developmental tyrosine kinases and their ligands
US7534867B1 (en) 1993-05-19 2009-05-19 Schering Corporation Purified mammalian Flt3 ligands; agonists; antagonists
AU7017494A (en) * 1993-05-19 1994-12-12 Institut National De La Sante Et De La Recherche Medicale Purified mammalian flt3 ligands and agonists and antagonists thereof
US5554512A (en) * 1993-05-24 1996-09-10 Immunex Corporation Ligands for flt3 receptors
NZ314644A (en) * 1993-05-24 2000-11-24 Immunex Corp Use of flt3-ligands as a growth stimulator of stem cells in the transplantation of tissue
US6630143B1 (en) * 1993-05-24 2003-10-07 Immunex Corporation Antibodies against flt3 ligand
US7045128B2 (en) 1993-05-24 2006-05-16 Immunex Corporation Antibodies against flt3-ligand
WO1995000554A2 (en) * 1993-06-18 1995-01-05 The Trustees Of Princeton University Totipotent hematopoietic stem cell receptors and their ligands
US5516658A (en) * 1993-08-20 1996-05-14 Immunex Corporation DNA encoding cytokines that bind the cell surface receptor hek
ATE336262T1 (de) * 1993-09-08 2006-09-15 Imclone Systems Inc Monoklonale antikörper die flk-2 rezeptoren erkennen, und die isolierung primitiver hämatopoietischer stammzellpopulationen
WO1995014776A1 (en) * 1993-11-23 1995-06-01 Genentech, Inc. PROTEIN TYROSINE KINASES NAMED Rse
US6001621A (en) * 1993-11-23 1999-12-14 Genetech, Inc. Protein tyrosine kinases
US6190655B1 (en) 1993-12-03 2001-02-20 Immunex Corporation Methods of using Flt-3 ligand for exogenous gene transfer
US5618709A (en) * 1994-01-14 1997-04-08 University Of Pennsylvania Antisense oligonucleotides specific for STK-1 and method for inhibiting expression of the STK-1 protein
US5573935A (en) * 1994-01-18 1996-11-12 The United States Of America As Represented By The Department Of Health And Human Services Protein tyrosine kinase A6
US6448077B1 (en) * 1994-02-10 2002-09-10 Imclone Systems, Inc. Chimeric and humanized monoclonal antibodies specific to VEGF receptors
US6811779B2 (en) * 1994-02-10 2004-11-02 Imclone Systems Incorporated Methods for reducing tumor growth with VEGF receptor antibody combined with radiation and chemotherapy
US20030108545A1 (en) * 1994-02-10 2003-06-12 Patricia Rockwell Combination methods of inhibiting tumor growth with a vascular endothelial growth factor receptor antagonist
US5840301A (en) * 1994-02-10 1998-11-24 Imclone Systems Incorporated Methods of use of chimerized, humanized, and single chain antibodies specific to VEGF receptors
US5861499A (en) 1994-02-10 1999-01-19 Imclone Systems Incorporated Nucleic acid molecules encoding the variable or hypervariable region of a monoclonal antibody that binds to an extracellular domain
US7294331B2 (en) * 1994-03-07 2007-11-13 Immunex Corporation Methods of using flt3-ligand in hematopoietic cell transplantation
DK0751992T3 (da) * 1994-03-08 2006-03-06 Human Genome Sciences Inc Karendotelvækstfaktor 2
US7153827B1 (en) * 1994-03-08 2006-12-26 Human Genome Sciences, Inc. Vascular endothelial growth factor 2 and methods of use
US7186688B1 (en) * 1994-03-08 2007-03-06 Human Genome Sciences, Inc. Methods of stimulating angiogenesis in a patient by administering vascular endothelial growth factor 2
US6734285B2 (en) 1994-03-08 2004-05-11 Human Genome Sciences, Inc. Vascular endothelial growth factor 2 proteins and compositions
US6608182B1 (en) 1994-03-08 2003-08-19 Human Genome Sciences, Inc. Human vascular endothelial growth factor 2
US6040157A (en) * 1994-03-08 2000-03-21 Human Genome Sciences, Inc. Vascular endothelial growth factor 2
US7109308B1 (en) * 1994-03-08 2006-09-19 Human Genome Sciences, Inc. Antibodies to human vascular endothelial growth factor 2
US5932540A (en) 1994-03-08 1999-08-03 Human Genome Sciences, Inc. Vascular endothelial growth factor 2
US5650317A (en) * 1994-09-16 1997-07-22 Michigan State University Human breast epithelial cell type with stem cell and luminal epithelial cell characteristics
US6140119A (en) * 1994-09-16 2000-10-31 Michigan State University Expression of estrogen receptors in type I and type II human breast epithelial cells
US5731425A (en) * 1994-10-28 1998-03-24 Eastman Kodak Company Polypeptide surface marker for cells
CA2208319A1 (en) * 1994-12-23 1996-07-04 Ludwig Institute For Cancer Research Assay, receptor proteins and ligands
US7070972B1 (en) 1995-01-13 2006-07-04 The United States Of America As Represented By The Department Of Health And Human Services Janus family kinases and identification of immune modulators
IL117645A (en) * 1995-03-30 2005-08-31 Genentech Inc Vascular endothelial cell growth factor antagonists for use as medicaments in the treatment of age-related macular degeneration
US5824789A (en) * 1995-06-07 1998-10-20 Systemix, Inc. Human growth factors, nucleotide sequence encoding growth factors, and method of use thereof
EP1382679A3 (de) * 1995-09-08 2004-11-10 Genentech, Inc. Antagonisten gegen Vaskuläres Endothelzellen Wachstumsfaktor-verwandtes Protein (VRP)
US7150992B1 (en) 1995-10-04 2006-12-19 Innunex Corporation Methods of preparing dendritic cells with flt3-ligand and antigen
US7361330B2 (en) * 1995-10-04 2008-04-22 Immunex Corporation Methods of using flt3-ligand in the treatment of fibrosarcoma
US20020034517A1 (en) * 1995-10-04 2002-03-21 Kenneth Brasel Dendritic cell stimulatory factor
US6994989B1 (en) 1995-11-08 2006-02-07 Immunex Corp. FLK-1 binding proteins
AU1116297A (en) * 1995-11-08 1997-05-29 Immunex Corporation Flk-1 binding protein
US5869243A (en) * 1996-03-05 1999-02-09 Rhode Island Hospital Immortalized hepatocytes
US6100071A (en) * 1996-05-07 2000-08-08 Genentech, Inc. Receptors as novel inhibitors of vascular endothelial growth factor activity and processes for their production
US6750044B1 (en) * 1996-10-17 2004-06-15 Genentech, Inc. Variants of vascular endothelial cell growth factor having antagonistic properties, nucleic acids encoding the same and host cells comprising those nucleic acids
US20060171907A1 (en) * 1996-11-21 2006-08-03 The Procter & Gamble Company Oral care compositions providing enhanced whitening and stain prevention
AU2469299A (en) * 1998-01-23 1999-08-09 Cornell Research Foundation Inc. Purified populations of stem cells
US6908898B1 (en) * 1998-06-15 2005-06-21 Lars Holmgren Angiogenesis related molecules
NZ529063A (en) * 1998-10-09 2005-07-29 Ludwig Inst Cancer Res Flt4 (VEGFR-3) as a target for tumor imaging and anti-tumor therapy
US8124630B2 (en) 1999-01-13 2012-02-28 Bayer Healthcare Llc ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
ATE556713T1 (de) * 1999-01-13 2012-05-15 Bayer Healthcare Llc Omega-carboxyarylsubstituierte-diphenyl- harnstoffe als p38-kinasehemmer
US20020064528A1 (en) * 2000-01-28 2002-05-30 Zhenping Zhu Antibodies specific to KDR and uses thereof
US7223724B1 (en) * 1999-02-08 2007-05-29 Human Genome Sciences, Inc. Use of vascular endothelial growth factor to treat photoreceptor cells
US6379903B1 (en) * 1999-10-08 2002-04-30 Sigma-Aldrich Co. Purification of recombinant proteins fused to multiple epitopes
DE60114196T2 (de) 2000-06-07 2006-07-20 Ortho-Mcneil Pharmaceutical, Inc. Verfahren zur erkennung von modulatoren der vegf-kinase-domäne
US7273751B2 (en) * 2000-08-04 2007-09-25 Human Genome Science, Inc. Vascular endothelial growth factor-2
JP4669984B2 (ja) 2001-01-19 2011-04-13 ベジェニクス リミテッド 腫瘍画像化のターゲットとしてのＦ１ｔ４（ＶＥＧＦＲ−３）および抗腫瘍療法
US20050232921A1 (en) * 2001-04-13 2005-10-20 Rosen Craig A Vascular endothelial growth factor 2
CA2444624A1 (en) * 2001-04-13 2002-10-24 Human Genome Sciences, Inc. Vascular endothelial growth factor 2
ATE470676T1 (de) 2001-04-13 2010-06-15 Human Genome Sciences Inc Anti-vegf-2 antikörper
US20030170786A1 (en) * 2001-04-13 2003-09-11 Rosen Craig A. Vascular endothelial growth factor 2
US7402312B2 (en) * 2001-04-13 2008-07-22 Human Genome Sciences, Inc. Antibodies to vascular endothelial growth factor 2 (VEGF-2)
US7371763B2 (en) * 2001-04-20 2008-05-13 Bayer Pharmaceuticals Corporation Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureas
JP2005508298A (ja) * 2001-06-20 2005-03-31 イムクローン システムズ インコーポレイティド アテローム性動脈硬化症及び他の炎症性疾患を処置する方法
EP1423012B1 (de) * 2001-08-10 2007-11-14 Imclone Systems, Inc. Medizinische verwendung von stammzellen, die vegfr-1 exprimieren
US20080108672A1 (en) * 2002-01-11 2008-05-08 Bernd Riedl Omega-Carboxyaryl Substituted Diphenyl Ureas As Raf Kinase Inhibitors
EP2324825A1 (de) * 2002-02-11 2011-05-25 Bayer Healthcare LLC Arylharnstoffe mit Angiogenese hemmender Aktivität
US7557129B2 (en) * 2003-02-28 2009-07-07 Bayer Healthcare Llc Cyanopyridine derivatives useful in the treatment of cancer and other disorders
PT1626714E (pt) * 2003-05-20 2007-08-24 Bayer Pharmaceuticals Corp Diarilureias para doenças mediadas por pdgfr
SI1663978T1 (sl) 2003-07-23 2008-02-29 Bayer Pharmaceuticals Corp Fluoro substituirana omega-karboksiaril difenil secnina za zdravljenje ali preprecevanje bolezni instanj
EP2377555A3 (de) 2004-11-18 2011-11-23 Imclone LLC Antikörper gegen den vaskulären endothelialen Wachstumsfaktorrezeptor-1
US7495383B2 (en) * 2005-08-01 2009-02-24 Avago Technologies Ecbu Ip (Singapore) Pte. Ltd. Phosphor based on a combination of quantum dot and conventional phosphors
KR100883430B1 (ko) * 2007-06-13 2009-02-12 한국생명공학연구원 혈관내피성장인자 수용체를 중화하는 인간 단클론항체 및그 용도
AR071891A1 (es) 2008-05-30 2010-07-21 Imclone Llc Anticuerpos humanos anti-flt3 (receptor tirosina cinasa 3 tipo fms humano)
US9029144B2 (en) * 2008-06-18 2015-05-12 Innovative Bio Therapies, Inc. Methods for enhanced propagation of cells
CA2901226C (en) 2013-02-18 2020-11-17 Vegenics Pty Limited Vascular endothelial growth factor binding proteins

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0317156B2 (de) * 1987-11-09 1997-11-12 Becton, Dickinson and Company Verfahren zur Analyse hämatopoietischer Zellen in einer Probe
HUT53672A (en) * 1988-02-25 1990-11-28 Gen Hospital Corp Quick immunoselective cloning process
US5081030A (en) * 1989-04-25 1992-01-14 The Johns Hopkins University Release of cells from affinity matrices
US5061620A (en) * 1990-03-30 1991-10-29 Systemix, Inc. Human hematopoietic stem cell
US5185438A (en) * 1991-04-02 1993-02-09 The Trustees Of Princeton University Nucleic acids encoding hencatoporetic stem cell receptor flk-2

Also Published As

Publication number Publication date
EP1808445A2 (de) 2007-07-18
CA2107463A1 (en) 1992-10-03
KR100406832B1 (ko) 2003-11-21
EP1231265B1 (de) 2007-01-31
EP1231265A3 (de) 2003-12-03
EP0909813B1 (de) 2002-07-17
DE69233676T2 (de) 2007-11-15
EP1808445A3 (de) 2007-09-26
WO1992017486A1 (en) 1992-10-15
EP1231261A2 (de) 2002-08-14
KR100261465B1 (ko) 2000-07-01
EP1231260A3 (de) 2003-12-03
US5621090A (en) 1997-04-15
US5185438A (en) 1993-02-09
AU1924892A (en) 1992-11-02
KR100407010B1 (ko) 2003-11-28
EP1231260A2 (de) 2002-08-14
EP0580760A4 (en) 1997-04-09
DE69232952D1 (de) 2003-04-17
EP0909813A1 (de) 1999-04-21
US5283354A (en) 1994-02-01
EP1231261A3 (de) 2003-12-03
EP0580760A1 (de) 1994-02-02
CA2107463C (en) 2008-06-17
EP0580760B1 (de) 2003-03-12
EP1231261B1 (de) 2010-06-23
DE69232952T2 (de) 2003-10-02
DE69233746D1 (de) 2008-10-30
DE69233676D1 (de) 2007-03-22
DE69233788D1 (de) 2010-08-05
EP1231265A2 (de) 2002-08-14
DE69232687T2 (de) 2002-11-21
EP1231260B1 (de) 2008-09-17
WO1993000349A1 (en) 1993-01-07

Similar Documents

Publication Publication Date Title
DE69232687D1 (de) Rezeptor flk-2 von pluripotenten hämatopoetischen Stammzellen
DE69322573D1 (de) Zellkultureinsatz
DE69319983D1 (de) Zellkultureinsatz
DE69013764T2 (de) Kontrolle der Zellanordnung.
FR2623583B2 (fr) Supports elastiques
MX164321B (es) Sosten
FR2617040B1 (fr) Prothese cotyloidienne
FI87937C (fi) Elektrolytisk cell
DE3868107D1 (de) Schwefel enthaltende boratester.
DE3856151D1 (de) Schreibmittel
FR2611486B1 (fr) Prothese uretrale
BR8906415A (pt) Composicao detergente contendo enzima
TR23694A (tr) G i z l i
ES2014335B3 (es) Jigger
ATA228888A (de) Verteilergarnitur
IT1219657B (it) Composizione antiepilettica
ES1001460Y (es) Hamaca
KR890013004U (ko) 송출식 봉상물 용기
FR2617258B1 (fr) Supports elastiques
BR6700474U (pt) Lapiseira colegial
BR6700297U (pt) Involucro suporte
BR6702550U (pt) Calendario executivo
ES1002097Y (es) Cantimplora
KR890006157U (ko) 오르겐이 설치된 필통
SE8704438D0 (sv) Plattformsvag t ex badrumsvag

Legal Events

Date Code Title Description
8364 No opposition during term of opposition